Stem Cell Therapy

Chondrocyte and Mesenchymal Stem Cell-Based Therapies to Help Manage in Osteoarthritis and Other Orthopedic Conditions 

Osteoarthritis (OA) continues to be the most common form of degenerative joint disease in the United States and around the world.  According to the World Health Organization (WHO), 528 million people worldwide were living with osteoarthritis (OA) in 2019, which is an increase of 113% since 1990. The Global Burden of Disease Study 2021 found…

Advancements in Mesenchymal Stromal Cell Therapy for Cartilage Regeneration in Knee Osteoarthritis

Osteoarthritis (OA) is a prevalent and disabling joint condition that imposes significant health and economic burdens globally. Between 2006 and 2016, the global percentage change in years lived with disability due to OA increased by 31.5%. Knee osteoarthritis (KOA) is the most common form, primarily affecting older adults and those who are obese. Symptoms of…

Load More

Do you have questions?

We have answers. Speak with a Stemedix Care Coordinator today with no obligation. Give us a call!

Contact Us
Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.